Search - tctmd.com

Displaying 41 - 60 of 2550

Sort: Relevancy | Date

Presentation Miami Valves 2025

Dedicated TAVR Devices for Chronic Aortic Regurgitation

Presenter: Santiago Garcia

January 30, 2025

Presentation Miami Valves 2025

Clinical Trials Propel TAVR Forward

Presenter: Jeffrey Popma

January 30, 2025

Presentation Miami Valves 2025

Cases

Presenter: Antonio E Dager Gomez

January 30, 2025

Presentation Miami Valves 2025

AI Simulation Assisted TAVR

Presenter: Nikolaos Spilias

January 30, 2025

Presentation Miami Valves 2025

A Past Medical History of PE or DVT Impacts In-Hospital Outcomes of Patients Undergoing Elective Isolated Percutaneous Aortic Valve Replacement

Presenter: Lourdes Villarrubia Varela

January 30, 2025

Presentation Miami Valves 2025

A Case of Bicuspid TAVR with AI Planning

Presenter: Som Bailey

January 30, 2025

Presentation AHA 2024

Efficacy and safety of EdoxabaN in anticoagulant therapy after surgical Bioprosthetic vALVe replacement

Presenter: Chisato Izumi

November 17, 2024

Presentation TCT 2024

TCT 796: Association Between Social Determinants of Health and Aortic Valve Replacement in a Large Community-based Health Care System

Presenter: Daniel Spoon

October 30, 2024

Presentation TCT 2024

TCT 654: Treatment Patterns for Severe Aortic Stenosis in a Large Community-based Health Care System

Presenter: Daniel Spoon

October 30, 2024

Presentation TCT 2024

TCT 641: Time to Treatment for Severe Aortic Stenosis in a Large Community-based Health Care System

Presenter: Daniel Spoon

October 29, 2024

Presentation TCT 2024

The EARLY TAVR Trial Editorial Commentary

Presenter: Bernard Prendergast

October 28, 2024

Presentation ESC 2024

RHEIA: Randomized researcH in womEn all comers wIth Aortic stenosis

Presenter: Hélène Eltchaninoff

August 31, 2024

Presentation ESC 2024

NOTION-3: PCI in patients undergoing transcatheter aortic valve implantation

Presenter: Jacob Lønborg

August 31, 2024

Presentation ESC 2024

Continuation versus Interruption of Oral Anticoagulation during TAVI

Presenter: Dirk-Jan van Ginkel

August 31, 2024

Presentation EuroPCR 2024

Long-term outcomes of transcatheter aortic valve vs. surgical aortic valve replacement

Presenter: Eliano Navarese

May 15, 2024

Presentation EuroPCR 2024

First TAVI vs. SAVR randomised trial in younger low-risk patients with severe tricuspid or bicuspid aortic valve stenosis - results from NOTION-2

Presenter: Ole De Backer

May 15, 2024

Presentation EuroPCR 2024

First report of an IDE pivotal study of a dedicated splitting device during TAVR

Presenter: Danny Dvir

May 15, 2024

Presentation EuroPCR 2024

Early outcomes of a randomised non-inferiority trial comparing TAVI devices: the LANDMARK trial

Presenter: Patrick Serruys

May 15, 2024

Presentation EuroPCR 2024

Using temporary permanent pacemaker as a one-month bridge after TAVI

Presenter: Guangyuan Song

May 14, 2024

Advertisement

Dedicated TAVR Devices for Chronic Aortic Regurgitation

Clinical Trials Propel TAVR Forward

Cases

AI Simulation Assisted TAVR

A Past Medical History of PE or DVT Impacts In-Hospital Outcomes of Patients Undergoing Elective Isolated Percutaneous Aortic Valve Replacement

A Case of Bicuspid TAVR with AI Planning

Efficacy and safety of EdoxabaN in anticoagulant therapy after surgical Bioprosthetic vALVe replacement

TCT 796: Association Between Social Determinants of Health and Aortic Valve Replacement in a Large Community-based Health Care System

TCT 654: Treatment Patterns for Severe Aortic Stenosis in a Large Community-based Health Care System

TCT 641: Time to Treatment for Severe Aortic Stenosis in a Large Community-based Health Care System

The EARLY TAVR Trial Editorial Commentary

RHEIA: Randomized researcH in womEn all comers wIth Aortic stenosis

NOTION-3: PCI in patients undergoing transcatheter aortic valve implantation

Continuation versus Interruption of Oral Anticoagulation during TAVI

Long-term outcomes of transcatheter aortic valve vs. surgical aortic valve replacement

First TAVI vs. SAVR randomised trial in younger low-risk patients with severe tricuspid or bicuspid aortic valve stenosis - results from NOTION-2

First report of an IDE pivotal study of a dedicated splitting device during TAVR

Early outcomes of a randomised non-inferiority trial comparing TAVI devices: the LANDMARK trial

Using temporary permanent pacemaker as a one-month bridge after TAVI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content